Biogen (BIIB) market cap

Market cap today
$37.07B

Biogen (BIIB) has a market cap of $37.07B. At the end of fiscal 2025 (December 31, 2025) its market cap was $25.89B. That is 16.0% higher than the $22.31B of fiscal 2024. Today's figure is 43.2% above the fiscal 2025 year-end. Figures as of 18 Nov 2026, 09:38 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Market cap today
$37.07B
Market cap, fiscal 2025
$25.89B
Change on fiscal 2024
+16.0%
Growth, 5 years
−8.1% a year
Growth, 10 years
−9.6% a year
Highest on record
$80.52Bfiscal 2014
Lowest on record
$14.05Bfiscal 2008
Fiscal years on record
192007–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

Biogen market cap, in more detail

Over the five fiscal years to 2025 the market cap shrank at a compound 8.1% a year; over ten years the rate was −9.6% a year. Across the 19 fiscal year-ends on record (2007–2025), the highest was $80.52B in fiscal 2014 and the lowest $14.05B in fiscal 2008.

History · 19 fiscal years

Market cap at each fiscal year-end

The last point is today's figure; the others are fiscal year-ends.

Biogen market cap, year by year

Biogen (BIIB) market cap by fiscal year
Fiscal yearMarket capChangeYear endedShare price at year-endDiluted shares
Today$37.07B—$250.79—
2025$25.89B 16.0% up$175.99147.10M
2024$22.31B 40.8% down$152.92145.90M
2023$37.68B 6.8% down$258.77145.60M
2022$40.43B 12.6% up$276.92146.00M
2021$35.89B 9.1% down$239.92149.60M
2020$39.50B 29.0% down$244.86161.30M
2019$55.61B 10.0% down$296.73187.40M
2018$61.78B 9.0% down$300.92205.30M
2017$67.86B 9.4% up$318.57213.00M
2016$62.05B 12.4% down$283.58218.80M
2015$70.83B 12.0% down$306.35231.20M
2014$80.52B 20.9% up$339.45237.20M
2013$66.62B 89.9% up$279.57238.30M
2012$35.09B 30.1% up$146.37239.74M
2011$26.97B 57.8% up$110.05245.03M
2010$17.09B 10.3% up$67.05254.87M
2009$15.49B 10.2% up$53.50289.48M
2008$14.05B 22.9% down$47.63294.98M
2007$18.22B—$56.92320.17M

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Market cap is the share price multiplied by the number of shares: for past years this page multiplies the diluted share count in each annual report by the closing price for the month that fiscal year ended in, and today's figure comes from the live quote.

How to read it

It is what the stock market says the whole company is worth — a measure of size, not of whether the shares are cheap or dear.

Market cap at health care companies of similar size

Market cap of Biogen and comparable companies
CompanyMarket cap
Royalty Pharma RPRX$39.49B
Biogen BIIB$37.07B
GE HealthCare Technologies GEHC$37.00B
Alcon ALC$35.60B
Mettler-Toledo International MTD$34.07B
Centene CNC$35.92B

Today's market value as the market data feed reports it, each in the currency its shares trade in.

More on BIIB

Biogen, figure by figure

Biogen (BIIB) overview: price, valuation and scorecardAll health care companies by market value

Biogen market cap: questions and answers

What is Biogen's market cap?

Biogen (BIIB) has a market cap of $37.07B. At the end of fiscal 2025 (December 31, 2025) its market cap was $25.89B. That is 16.0% higher than the $22.31B of fiscal 2024.

What is the growth rate of Biogen's market cap?

Over the five fiscal years to 2025 the market cap shrank at a compound 8.1% a year; over ten years the rate was −9.6% a year.

What are the highest and lowest market cap figures on record for Biogen?

Across the 19 fiscal year-ends on record (2007–2025), the highest was $80.52B in fiscal 2014 and the lowest $14.05B in fiscal 2008.

How is Biogen's market cap calculated?

Market cap is the share price multiplied by the number of shares: for past years this page multiplies the diluted share count in each annual report by the closing price for the month that fiscal year ended in, and today's figure comes from the live quote. For Biogen it is on record here for 19 fiscal years, 2007 to 2025.

Share prices are Yahoo Finance's monthly closes: a fiscal year-end is paired with the close of the month it falls in, and today's quote may be delayed. Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Biogen (BIIB) market cap”, data as of 18 November 2026. https://funkfolio.com/stock/BIIB/market-cap

Underlying data: the company's filings with the SEC and Yahoo Finance.